What happened inVentiv Health?
What happened inVentiv Health?
RALEIGH, N.C. – January 4, 2018 – INC Research/inVentiv Health (Nasdaq: INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. Our Biopharmaceutical Acceleration Model is unique to the industry, and from this ambitious vision, Syneos Health was born.”
Who bought inVentiv?
Thomas H. Lee Partners
Thomas H. Lee Partners bought inVentiv in 2010 for approximately $1.1 billion.
Did Syneos buy inVentiv?
With their $7.4 billion merger complete, Raleigh-based INC Research and InVentiv have rebranded as Syneos Health Inc. The Contract Research Organization (CRO) and Contract Commercial Organization (CCO) formed by the merger trades on Nasdaq under the symbol SYNH.
When did inVentiv become Syneos?
January 4, 2018
RALEIGH, N.C. , Jan. 04, 2018 (GLOBE NEWSWIRE) — INC Research/inVentiv Health (Nasdaq:INCR) today announced it has changed its brand identity to Syneos Health, Inc. , effective January 4, 2018 .
Who is the CEO of Syneos Health?
Alistair MacDonald (2016–)
Syneos Health/CEO
A Message from Syneos Health CEO Alistair Macdonald. Dear Valued Customers, Partners and Industry Colleagues, Syneos Health shares its heartfelt empathy with the communities impacted worldwide by COVID-19.
Who did Syneos merger with?
Syneos Health, a company combining contract research organization (CRO) and contract commercial organization (CRO) capabilities, has inked an agreement to acquire Synteract, a biopharma-focused CRO. The acquired company offers expertise in oncology, rare and orphan diseases, neuroscience, dermatology, and pediatrics.
What did Syneos used to be?
Syneos Health (formerly InVentiv Health Incorporated and INC Research) is a NASDAQ listed American multinational contract research organization based in Morrisville, North Carolina.
What kind of company is Syneos Health?
biopharmaceutical solutions company
Syneos Health® is an end-to-end, fully integrated biopharmaceutical solutions company that works differently. At Syneos Health, all the disciplines involved in bringing new therapies to market, from clinical to commercial, work together to create customer success.
Who owns Syneos?
INC Research
In January 2018 INC Research acquired inVentiv Health, the parent company of a subsidiary, Syneos, and the resulting company was named Syneos Health.
Who is inVentiv Health?
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentivs client roster includes more than 550 pharmaceutical, biotech and life sciences companies.
What is Inc research/inVentiv Health Communications?
inVentiv Health Communications is part of INC Research/inVentiv Health, a 22,000-employee global professional services organization designed to help the bio-pharmaceutical industry shorten the distance from lab to life.
Where can I learn more about the INC Research-inVentiv Health merger?
Learn more at www.inventivhealth.com Our exciting merger with INC Research is official. Integrating our best practices and processes creates a company that is a far better fit for the modern biopharmaceutical world. And it will have one purpose: Shortening the distance from lab to life.
Who is the owner of inVentiv?
It has served such notable clients as Johnson and Johnson, Bristol-Myers Squibb, and Novartis Pharmaceuticals. inVentiv is owned by private equity firms Thomas H. Lee Partners (THL) and Advent International. External Website. Opens New Window External Website.
